BIO-key International, Inc. (OTCMKTS:BKYI) insider Fong Wong Kwok purchased 26,300 shares of the firm’s stock in a transaction that occurred on Thursday, August 31st. The shares were bought at an average price of $3.10 per share, with a total value of $81,530.00. Following the completion of the acquisition, the insider now owns 1,345,737 shares of the company’s stock, valued at approximately $4,171,784.70. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

BIO-key International, Inc. (OTCMKTS BKYI) traded up 0.94% during mid-day trading on Friday, hitting $3.22. 9,397 shares of the company traded hands. BIO-key International, Inc. has a one year low of $0.13 and a one year high of $3.67. The company’s 50-day moving average price is $3.32 and its 200 day moving average price is $2.88. The company’s market capitalization is $20.92 million.

BIO-key International (OTCMKTS:BKYI) last posted its earnings results on Monday, August 14th. The technology company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.22) by $0.10. BIO-key International had a negative return on equity of 42.40% and a negative net margin of 95.62%. The business had revenue of $0.89 million for the quarter. On average, analysts anticipate that BIO-key International, Inc. will post ($0.75) earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Fong Wong Kwok Purchases 26,300 Shares of BIO-key International, Inc. (BKYI) Stock” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/09/01/fong-wong-kwok-purchases-26300-shares-of-bio-key-international-inc-bkyi-stock.html.

Separately, Maxim Group initiated coverage on shares of BIO-key International in a report on Thursday, July 13th. They set a “buy” rating and a $5.50 price target for the company.

About BIO-key International

BIO-key International, Inc develops and markets fingerprint biometric identification and identity verification technologies, cryptographic authentication-transaction security technologies, as well as related identity management and credentialing software solutions. The Company is also engaged in developing automated, finger identification technology that supplements or compliments other methods of identification and verification, such as personal inspection identification, passwords, tokens, smart cards, identity cards, public key infrastructure (PKI), credit card, passports, driver’s licenses, one-time password (OTP) or other form of possession or knowledge-based credentialing.

Receive News & Stock Ratings for BIO-key International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International Inc. and related stocks with our FREE daily email newsletter.